Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease

Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease

Osteonecrosis of the femoral head is a frequent complication in adult patients with sickle cell disease (SCD). To delay hip arthroplasty, core decompression combined with concentrated total bone marrow (BM) treatment is currently performed in the early stages of the osteonecrosis. Cell therapy effic...

Full description

Bibliographic Details
Main Authors: Angélique Lebouvier, Alexandre Poignard, Laura Coquelin-Salsac, Julie Léotot, Yasuhiro Homma, Nicolas Jullien, Philippe Bierling, Frédéric Galactéros, Philippe Hernigou, Nathalie Chevallier, Hélène Rouard
Format: Article
Language:English
Published: Elsevier 2015-11-01
Series:Stem Cell Research
Subjects:
Bone marrow stromal cells
Sickle cell disease
Osteonecrosis
Bone regeneration
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506115001361

Internet

http://www.sciencedirect.com/science/article/pii/S1873506115001361

Similar Items